CVC Capital Proposes €1.2B Offer for CompuGroup Medical

CompuGroup Medical is in advanced discussions with CVC Capital Partners for a potential takeover valued at €22 per share, a significant premium over its recent trading price of approximately €16. This acquisition, estimated at around €1.14 billion, would allow the founding Gotthardt family to retain a 50.1% stake while establishing a strategic partnership with CVC. The company has seen its shares drop over 55% this year, reaching a 10-year low due to a profit warning issued earlier in July. Following the takeover, CompuGroup's shares would likely be delisted from the stock exchange. The deal is seen as a crucial turning point for the struggling healthcare software provider, which has faced challenging market conditions recently.